Safety of cardiac surgery without blood transfusion: A retrospective study in Jehovah's Witness patients: Original article

Anaesthesia

Volumn 65, Issue 4, 2010, Pages 348-352

  El Azab, S R ^a,b   Vrakking, R ^d   Verhage, G ^d   Rosseel, P M J ^c  

^a King Fahd Specialist Hospital Buraidah   (Saudi Arabia)

^b AL AZHAR UNIVERSITY   (Egypt)

^c AMPHIA HOSPITAL   (Netherlands)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL READMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; JEHOVAH'S WITNESS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; Q WAVE; RETROSPECTIVE STUDY; SAFETY; TREATMENT OUTCOME;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CLINICAL PROTOCOLS; CORONARY ARTERY BYPASS; FEMALE; HEMOSTASIS, SURGICAL; HUMANS; INTENSIVE CARE UNITS; JEHOVAH'S WITNESSES; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RELIGION AND MEDICINE; RETROSPECTIVE STUDIES;

EID: 77949690980     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2009.06232.x     Document Type: Article

References (28)

1. Covin R, O'Brien M, Grunwald G, et al. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. Archives of Pathology and Laboratory Medicine 2003 127 : 415 423.
2. Belisle S, Hardy JF. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Annals of Thoracic Surgery 1996 62 : 1908 1917.
3. Steiner ME, Despotis GJ. Transfusion algorithms and how they apply to blood conservation: the high-risk cardiac surgical patient. Hematology/Oncology Clinics of North America 2007 21 : 177 184.
4. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Archives of Pathology & Laboratory Medicine 2007 131 : 708 718.
5. Taylor RW, Manganaro LRN, O'Brien JRN, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Critical Care Medicine 2002 30 : 2249 2254.
6. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002 42 : 812 818.
7. Williams FG. Consent for transfusion. British Medical Journal 1997 315 : 380 381.
8. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. British Journal of Anaesthesia 2005 95 : 33 42.
9. Goodnough LT. Risks of blood transfusion. Critical Care Medicine 2003 31 : S678 86.
10. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. British Medical Bulletin 2004 70 : 15 28.
11. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfusion Medicine Reviews 2003 17 : 120 162.
12. Williamson LM, Lowe S, Love EM, et al. Serious Hazards of Transfusion (SHOT) initiative: analysis of the first two annual reports. British Medical Journal 1999 319 : 16 9.
13. Weinberg PD, Hounshell J, Sherman LA, et al. Legal, financial, and public health consequences of HIV contamination of blood and blood products in 1980s and 1990s. Annals of Internal Medicine 2002 136 : 312 319.
14. Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Archives of Pathology and Laboratory Medicine 2007 131 : 708 718.
15. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005 105 : 2266 2273.
16. Herbert PC, Wells G, Blajchman MA, et al. A multicenter randomised controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care Investigators, Canadian Critical Care Trials Group. New England Journal of Medicine 1999 340 : 409 417.
17. Kuduvalli M, Oo AY, Newall N, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. European Journal of Cardiothoracic Surgery 2005 27 : 592 598.
18. Surgenor SD, DeFoe GR, Fillinger MP, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006 114 : 43 8.
19. The Watchtower June 15, 2004 p24 paragraph 16
20. Fang WC, Helm RE, Kreigger KH, et al. Impact of minimum haematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery. Circulation 1997 96 : II 194 9.
21. Mähönen MS, McElduff P, Dobson AJ, Kuulasmaa KA, Evans AE. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tobacco Control 2004 13 : 244 250.
22. Licker M, Ellenberger C, Sierra J, Kalangos A, Diaper J, Morel D. Cardio protective effects of acute normovolemic hemodilution in patients undergoing coronary artery bypass surgery. Chest 2005 128 : 838 847.
23. Trouwborst A, Hagenouw RRPM, Jeekel J, Ong GL. Hypervolaemic haemodilution in an anaemic Jehovah's Witness. British Journal of Anaesthesia 1990 64 : 646 648.
24. Bojanov G, Belani KG. Aprotinin - an update for the perioperative physician. Annals of Cardiac Anaesthesia 2005 8 : 75 80.
25. Van der Linden PJ, Hardy JF, Daper A, Trenchant A, De Hert SG. Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome? British Journal of Anaesthesia 2007 99 : 646 652.
26. Cosgrove DM, Heric B, Lytle BW, et al. Aprotinin for reoperative myocardial revascularization: a placebo-controlled study. Annals of Thoracic Surgery 1992 54 : 1031 1038.
27. D'Ambra MN, Gray RJ, Hillman R, et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Annals of Thoracic Surgery 1997 64 : 1686 1693.
28. Yazicio ̀lu L, Eryilmaz S, Şirlak M, et al. Recombinant human erythropoietin administration in cardiac surgery. Journal of Thoracic and Cardiovascular Surgery 2001 122 : 741 745.